Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases

Psoriasis is a chronic skin disease caused by the excessive secretion of inflammatory cytokines. Available therapeutic options include biologic drugs such as tumor necrosis factor alpha inhibitors and interleukin 12/23 (IL-12/23) inhibitors. The recent discovery of IL-17, which contributes to develo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Postepy Dermatol Alergol
Autors principals: Wasilewska, Agnieszka, Winiarska, Marta, Olszewska, Małgorzata, Rudnicka, Lidia
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2016
Matèries:
Review Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004212/
https://ncbi.nlm.nih.gov/pubmed/27605893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2016.61599
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars